Skip to main content
. Author manuscript; available in PMC: 2020 Mar 27.
Published in final edited form as: Immunol Lett. 2017 Mar 18;189:27–39. doi: 10.1016/j.imlet.2017.03.010

Fig. 1. Overview of targets typically modulated by anti-allergic drugs.

Fig. 1

Figure shows a schematic T cell with relevant transmembrane receptors and ion channels inserted into the plasma membrane. The cytosol contains different signaling and metabolic pathways and a nucleus containing DNA and relevant transcription factors. The different anti-allergic and immunosupressive drugs and novel experimental substances (red font) and their targeted structures (red arrows) are depicted. Messenger RNA targeted by a DNAzyme is shown in blue. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)